Related Experiment Video
Updated: Jan 19, 2026

Measuring Caenorhabditis elegans Sensitivity to the Acetylcholine Receptor Agonist Levamisole
Published on: June 7, 2022
β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists
Ricardo Rosas1, Xi-Ping Huang2, Bryan L Roth2,3
1Department of Chemistry, Marquette University, P.O. Box 1881, Milwaukee, Wisconsin 53201-1881, United States.
New fentanyl analogs with reduced basicity show pH-dependent activity, selectively targeting low pH tissues. This discovery supports targeted pain relief for inflammatory pain with potentially lower abuse potential.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Neuroscience
Background:
- Mu opioid receptor (MOR) agonists with attenuated basicity may exhibit pH-dependent activity.
- Selective action at low pH tissues, such as damaged sites, is a potential therapeutic strategy.
Purpose of the Study:
- To synthesize and evaluate novel fentanyl analogs with modified basicity for pH-dependent mu opioid receptor activity.
- To investigate the potential of these compounds as targeted analgesics for inflammatory pain.
Main Methods:
- Synthesis of fentanyl analogs with fluorine substitutions on the phenethylamine side chain.
- In vitro evaluation of mu opioid receptor (MOR) activity using cAMP assays at different pH levels (7.4 and 6.5).
Main Results:
- A novel bis-fluorinated analog (RR-49) demonstrated superior pH sensitivity.
- RR-49 exhibited full efficacy and a 19-fold increase in potency at pH 6.5 compared to pH 7.4.
- The compound showed significantly higher potency at lower pH, indicating selective activity.
Conclusions:
- Fluorinated fentanyl analogs with attenuated basicity can achieve pH-dependent mu opioid receptor modulation.
- These compounds show promise for developing analgesics that target inflammatory pain with reduced side effects and abuse potential.
Related Concept Videos
08:11Measuring Caenorhabditis elegans Sensitivity to the Acetylcholine Receptor Agonist Levamisole
Opioid Receptors: Overview
11:45Quantifying Agonist Activity at G Protein-coupled Receptors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
02:07Stimulation of Dorsal Root Ganglion Sensory Neurons Using a Neuropeptide Receptor Agonist
